• price to book forward of acrivon therapeutics, inc. – nasdaq:acrv TradingView Sat, 27 Jun 2026 06:25:02 GMT
• Price to sales forward of Acrivon Therapeutics, Inc. – NASDAQ:ACRV TradingView Sat, 27 Jun 2026 03:59:53 GMT
• Acrivon Therapeutics, Inc. Actuals & Estimates (NASDAQ:ACRV) TradingView Fri, 26 Jun 2026 06:34:16 GMT
• Acrivon Therapeutics (ACRV) Slips 2.47% in Low-Volume Trade, Testing Key Support at $1.5 - Sector ETF Flow dars.gov.et Thu, 25 Jun 2026 07:00:00 GMT
• form 4 acrivon therapeutics inc for: 22 june by investing.com Investing.com UK Mon, 22 Jun 2026 20:14:00 GMT
• Acrivon Therapeutics (ACRV) director granted options on 20,275 shares Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Acrivon Therapeutics (ACRV) director receives 20,275 stock options at $1.52 strike Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Acrivon Therapeutics (ACRV) director Sharon Shacham awarded 20,275 stock options Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Acrivon (NASDAQ: ACRV) director granted 20,275 stock options at $1.52 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Director-linked RA Capital funds receive 20,275 Acrivon (ACRV) stock options at $1.52 Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Acrivon Therapeutics (ACRV) director awarded 20,275-share option for RA Capital funds Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• acrivon therapeutics inc (acrv) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• acrivon shareholders approve expanded equity plan and directors The Globe and Mail Thu, 18 Jun 2026 23:06:00 GMT
• acrivon therapeutics stockholders approve amended 2022 equity incentive plan and elect new directors – june 2026 Minichart Thu, 18 Jun 2026 00:45:00 GMT
• acrivon shareholders approve expanded equity plan and directors TipRanks Wed, 17 Jun 2026 23:05:24 GMT
• acrivon amends equity plan, shareholders approve 3,000,000-share increase TradingView Wed, 17 Jun 2026 21:33:00 GMT
• acrivon therapeutics inc (acrv) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 18:59:02 GMT
• acrivon therapeutics inc (acrv) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 18:50:14 GMT
• acrivon therapeutics inc (acrv) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 18:20:00 GMT
• acrivon therapeutics inc (acrv) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 17:24:25 GMT
• acrivon therapeutics inc (acrv) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 16:55:11 GMT
• acrivon therapeutics inc (acrv) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 16:55:07 GMT
• acrivon therapeutics inc (acrv) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 16:51:51 GMT
• acrivon therapeutics (acrv) shareholders approve larger equity plan and elect directors Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• acrivon therapeutics shareholders approve equity plan changes and director elections Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• acrivon therapeutics inc (acrv) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• gabelli initiates acrivon therapeutics(acrv.us) with buy rating, announces target price $8 Moomoo Mon, 15 Jun 2026 13:31:00 GMT
• acrivon therapeutics assumed with an outperform at oppenheimer TipRanks Mon, 15 Jun 2026 12:09:34 GMT
• oppenheimer initiates acrivon therapeutics(acrv.us) with buy rating, announces target price $8 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• acrivon therapeutics inc (acrv) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• acrivon therapeutics inc (acrv) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 15 Jun 2026 07:00:00 GMT
• acrivon therapeutics (acrv) shows modest upside amidst key technical levels - dealer delta newsline.com Sun, 14 Jun 2026 16:40:43 GMT
• acrivon therapeutics (acrv) faces continued pressure, testing key support after 7.7% decline - large cap trends newsline.com Sun, 07 Jun 2026 07:00:00 GMT
• acrv q1 2026 earnings: eps beat guidance, stock declines amid pre-revenue stage - annual earnings summary dars.gov.et Sat, 06 Jun 2026 07:00:00 GMT
• Acrivon Therapeutics (ACRV) Slides 7.7% as Support Test Looms After Bearish Momentum - Linear Regression dars.gov.et Fri, 05 Jun 2026 07:00:00 GMT
• acrv q1 2026 earnings: eps beats estimates as clinical pipeline advances - earnings power value newsline.com Thu, 04 Jun 2026 07:00:00 GMT
• Wall Street Analysts Are Bullish on Top Healthcare Picks The Globe and Mail Mon, 01 Jun 2026 07:00:00 GMT
• acrv stock price, quote & chart | acrivon therapeutics inc (nasdaq:acrv) ChartMill Mon, 01 Jun 2026 07:00:00 GMT
• Acrivon Therapeutics (ACRV) Slides 1.23% as Stock Tests Key Support at $1.53 - OBV Trend Line dars.gov.et Fri, 29 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) holds near support after modest decline - sell signal alerts newsline.com Fri, 29 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) holds steady near key support levels - retracement entry newsline.com Wed, 27 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) edges higher: biotech stock tests key resistance at $1.77 - double ema newsline.com Wed, 27 May 2026 07:00:00 GMT
• acrivon (acrv) ceo and evp report rsu-related tax withholding move Stock Titan Tue, 26 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) slides 1.71% as stock nears critical support zone - stock buy zone newsline.com Tue, 26 May 2026 07:00:00 GMT
• acrv q1 2026 earnings: narrower-than-expected loss underscores disciplined cash management - adjusted earnings analysis newsline.com Sat, 23 May 2026 07:00:00 GMT
• acrivon therapeutics to present at td cowen’s 7th annual oncology innovation summit Sahm Fri, 22 May 2026 08:55:25 GMT
• acrv stock price, quote & chart | acrivon therapeutics inc (nasdaq:acrv) ChartMill Fri, 22 May 2026 07:00:00 GMT
• Acrivon Therapeutics CEO to Participate in Virtual Fireside Chat at TD Cowen’s 7th Annual Oncology Innovation Summit Quiver Quantitative Thu, 21 May 2026 07:00:00 GMT
• acrivon therapeutics to present at td cowen’s 7th annual oncology innovation summit Yahoo Finance Thu, 21 May 2026 07:00:00 GMT
• acrivon ceo to join td cowen cancer innovation webcast may 26 Stock Titan Thu, 21 May 2026 07:00:00 GMT
• acrivon therapeutics’ swot analysis: stock shows promise in cancer pipeline Investing.com India Thu, 21 May 2026 07:00:00 GMT
• Acrivon (ACRV) COO Eric Devroe receives 72,981 RSU stock grant Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) cfo awarded 46,167 rsus, holdings rise to 67,150 shares Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) leaders receive new rsu and stock grants Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) director receives 9,366 rsus vesting in 2027 Stock Titan Wed, 20 May 2026 07:00:00 GMT
• 9,366 rsus granted to acrivon (acrv) director for ra capital funds Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon (acrv) director receives 9,366 restricted stock units as equity award Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) grants 49,830 rsus to chief legal officer mary miller Stock Titan Wed, 20 May 2026 07:00:00 GMT
• director at acrivon therapeutics (acrv) awarded 9,366 rsus vesting 2027 Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) cdo receives 38,584-share rsu grant with staged vesting Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) cmo receives 38,817-share restricted stock unit grant Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) cao awarded 14,227 rsus in equity grant Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) director granted 9,366 restricted stock units Stock Titan Wed, 20 May 2026 07:00:00 GMT
• acrv technical analysis | trend, signals & chart patterns | acrivon therapeutics inc (nasdaq:acrv) ChartMill Wed, 20 May 2026 07:00:00 GMT
• acrv stock price, quote & chart | acrivon therapeutics inc (nasdaq:acrv) ChartMill Wed, 20 May 2026 07:00:00 GMT
• Pleasing Signs As A Number Of Insiders Buy Acrivon Therapeutics Stock simplywall.st Tue, 19 May 2026 07:00:00 GMT
• acrivon (nasdaq: acrv) clo has 184 shares withheld for rsu tax Stock Titan Mon, 18 May 2026 07:00:00 GMT
• acrivon therapeutics (acrv) cao reports 99-share tax withholding on rsu vesting Stock Titan Mon, 18 May 2026 07:00:00 GMT
• acrivon (acrv) cdo has 404 shares withheld to cover rsu tax liability Stock Titan Mon, 18 May 2026 07:00:00 GMT
• acrivon (nasdaq: acrv) leaders use 1,743 shares for rsu tax withholding Stock Titan Mon, 18 May 2026 07:00:00 GMT
• [form 4] acrivon therapeutics, inc. insider trading activity Stock Titan Mon, 18 May 2026 07:00:00 GMT
• maxim group maintains acrivon therapeutics(acrv.us) with buy rating, maintains target price $7 Moomoo Sat, 16 May 2026 20:17:39 GMT
• acrivon pharmaceuticals: buy rating backed by strong cash runway and promising acr-368 phase 2 efficacy TipRanks Sat, 16 May 2026 19:43:14 GMT
• number of shareholders of acrivon therapeutics, inc. – nasdaq:acrv TradingView Sat, 16 May 2026 17:57:44 GMT
• citadel affiliates disclose 13‑share stake in acrivon (nasdaq: acrv) Stock Titan Fri, 15 May 2026 20:47:20 GMT
• new acrivon hire receives options for 111,150 company shares Stock Titan Fri, 15 May 2026 20:00:00 GMT
• Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• acrivon therapeutics, inc. (acrv) receives a buy from oppenheimer The Globe and Mail Fri, 15 May 2026 07:00:00 GMT
• citizens reiterates acrivon therapeutics stock rating on cancer trial progress by investing.com Investing.com Australia Fri, 15 May 2026 07:00:00 GMT
• td cowen maintains acrivon therapeutics(acrv.us) with buy rating 富途牛牛 Fri, 15 May 2026 00:48:21 GMT
• h.c. wainwright maintains acrivon therapeutics(acrv.us) with buy rating, maintains target price $19 富途牛牛 Thu, 14 May 2026 16:48:57 GMT
• analyst reiterates buy on acrivon, maintains $19 price target amid progress of acr-368 trials TipRanks Thu, 14 May 2026 11:47:13 GMT
• acrivon reports first quarter 2026 financial results and highlights progress towards key 2026 clinical catalysts Sahm Thu, 14 May 2026 10:59:15 GMT
• key facts: acrv acr-368 orr 39%; pd-1 combo p3 planned; q1 loss $19m TradingView Thu, 14 May 2026 07:55:34 GMT
• Citizens reiterates Acrivon Therapeutics stock rating on cancer trial progress Investing.com Thu, 14 May 2026 07:00:00 GMT
• Acrivon Reports First Quarter 2026 Financial Results and Highlights Progress Towards Key 2026 Clinical Catalysts GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• acrivon therapeutics, inc. 1q 2026: net loss $(19.0m), eps $(0.49) — 10-q summary TradingView Wed, 13 May 2026 07:00:00 GMT
• acrivon therapeutics reports q1 2026 net loss $19.0m; cash and investments $97.7m TradingView Wed, 13 May 2026 07:00:00 GMT
• brief-acrivon therapeutics, inc q1 income from operations usd -19.902 million TradingView Wed, 13 May 2026 07:00:00 GMT
• biotech acrivon has cash to advance cancer drugs into q3 2027 Stock Titan Wed, 13 May 2026 07:00:00 GMT
• acrivon therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Wed, 13 May 2026 07:00:00 GMT
• acrivon therapeutics (nasdaq: acrv) posts q1 loss and extends cash runway Stock Titan Wed, 13 May 2026 07:00:00 GMT
• acrivon (nasdaq: acrv) posts q1 2026 loss and extends cash runway Stock Titan Wed, 13 May 2026 07:00:00 GMT
• the strategic moves acrivon (acrv) is making now (-1.26%) 2026-05-11 - bullish pattern newser.com Mon, 11 May 2026 09:42:20 GMT
• acrivon therapeutics, inc. (nasdaq:acrv) given consensus recommendation of "moderate buy" by brokerages MarketBeat Sun, 10 May 2026 10:04:59 GMT
• why acrivon (acrv) valuation makes sense when you dig deeper (investor concern) 2026-05-07 - downside risk newser.com Thu, 07 May 2026 20:37:17 GMT
• acrv technical analysis | trend, signals & chart patterns | acrivon therapeutics inc (nasdaq:acrv) ChartMill Wed, 06 May 2026 07:00:00 GMT
• acrivon therapeutics | def 14a: definitive information statements Moomoo Thu, 30 Apr 2026 07:00:00 GMT
• acrivon therapeutics (nasdaq: acrv) sets 2026 virtual meeting, director and auditor votes Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• piper sandler resumed coverage on acrivon therapeutics with a new price target Quantisnow Tue, 28 Apr 2026 13:20:17 GMT
• acrivon therapeutics shares slide sharply following mixed oncology trial update MSN Tue, 28 Apr 2026 01:39:17 GMT
• acrivon therapeutics shares slide sharply following mixed oncology trial update MSN Mon, 27 Apr 2026 01:25:32 GMT
• acrivon therapeutics inc. (acrv) stock price | live quotes & charts | nasdaq StocksToTrade Fri, 24 Apr 2026 23:58:00 GMT
• acrv insider buying: ra capital acquires 3.89m shares april 24, 2026 Meyka Fri, 24 Apr 2026 07:00:00 GMT
• RA Capital funds add 3,888,888 Acrivon (ACRV) shares at $1.80 Stock Titan Thu, 23 Apr 2026 07:00:00 GMT
• ra capital boosts acrivon (acrv) stake to 28.8% after atm share buy Stock Titan Thu, 23 Apr 2026 07:00:00 GMT
• acrivon (acrv) chief legal officer has 558 shares withheld for rsu taxes Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• acrivon therapeutics | 4: statement of changes in beneficial ownership of securities-officer miller mary Moomoo Tue, 21 Apr 2026 07:00:00 GMT
• acrivon to highlight preclinical data with three posters at aacr demonstrating strong acr-368 and acr-2316 synergies with immune c... Sahm Sat, 18 Apr 2026 08:37:06 GMT
• acrivon therapeutics inc. (acrv) stock price | live quotes & charts | nasdaq StocksToTrade Sat, 18 Apr 2026 00:41:00 GMT
• cancer drug pairing drove complete tumor regression in acrivon lab study Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• acrivon to highlight preclinical data with three posters at aacr demonstrating strong acr-368 and acr-2316 synergies with immune c... Yahoo Finance Fri, 17 Apr 2026 07:00:00 GMT
• New Acrivon employee gets stock options for 111,150 shares Stock Titan Wed, 15 Apr 2026 07:00:00 GMT
• acrivon therapeutics announces inducement grant under nasdaq listing rule 5635(c)(4) Yahoo Finance Wed, 15 Apr 2026 07:00:00 GMT
• acrivon therapeutics, inc. (nasdaq:acrv) receives average recommendation of "moderate buy" from analysts MarketBeat Wed, 15 Apr 2026 07:00:00 GMT
• acrivon therapeutics (nasdaq:acrv) trading up 3.2% - still a buy? MarketBeat Tue, 14 Apr 2026 07:03:05 GMT
• portfolio update: what is acrivon therapeutics incs 5 year growth outlook - stop loss & weekly breakout opportunity watchlist baoquankhu1.vn Mon, 13 Apr 2026 09:17:01 GMT
• acrivon therapeutics inc. (acrv) stock price | live quotes & charts | nasdaq StocksToTrade Sat, 11 Apr 2026 00:39:00 GMT
• market catalysts: will acrivon therapeutics inc benefit from rate cuts - 2026 drop watch & daily stock momentum reports baoquankhu1.vn Thu, 09 Apr 2026 10:14:55 GMT
• portfolio shifts: can acrivon therapeutics inc expand into new markets - 2026 selloffs & smart allocation stock reports baoquankhu1.vn Tue, 07 Apr 2026 01:08:41 GMT
• aug intraday: is acrivon therapeutics inc a good esg investment - quarterly profit review & low risk high win rate picks baoquankhu1.vn Mon, 06 Apr 2026 16:06:08 GMT
• can acrivon (acrv) stock go higher | price at $1.61, up 5.92% - ipo watch Xã Thanh Hà Mon, 06 Apr 2026 07:00:00 GMT
• acrv stock price, quote & chart | acrivon therapeutics inc (nasdaq:acrv) ChartMill Thu, 02 Apr 2026 07:00:00 GMT
• acrv stock price, quote & chart | acrivon therapeutics inc (nasdaq:acrv) ChartMill Tue, 31 Mar 2026 07:00:00 GMT
• We're Keeping An Eye On Acrivon Therapeutics' (NASDAQ:ACRV) Cash Burn Rate simplywall.st Fri, 27 Mar 2026 07:00:00 GMT
• acrv stock price, quote & chart | acrivon therapeutics inc (nasdaq:acrv) ChartMill Fri, 27 Mar 2026 07:00:00 GMT
• acrv technical analysis | trend, signals & chart patterns | acrivon therapeutics inc (nasdaq:acrv) chartmill.com Fri, 27 Mar 2026 07:00:00 GMT
Acrivon Therapeutics, Inc.(NASDAQ:ACRV) 
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to specific medicine by utilizing its proteomics-based patient responder identification platform, Acrivon ...
Website: https://www.acrivon.com
Founded: 2018
Full Time Employees: 35
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends